Use of next generation sequencing in head and neck squamous cell carcinomas: A review

Oral Oncology

Volumn 50, Issue 11, 2014, Pages 1035-1040

  Tabatabaeifar, Siavosh ^a,b   Kruse, Torben A ^a,b   Thomassen, Mads ^a,b   Larsen, Martin J ^a,b   Sørensen, Jens A ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Exome sequencing; Head and neck cancer; Next generation sequencing; Recurrent mutations; Somatic mutations

Indexed keywords

GENOMIC DNA; NOTCH1 RECEPTOR;

ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CELL DIFFERENTIATION; COMPARATIVE STUDY; EXOME; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LOSS OF FUNCTION MUTATION; MOUTH SQUAMOUS CELL CARCINOMA; NEXT GENERATION SEQUENCING; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOMATIC MUTATION; WART VIRUS; GENETICS; HEAD AND NECK TUMOR; PROCEDURES; SEQUENCE ANALYSIS; SQUAMOUS CELL CARCINOMA;

CARCINOMA, SQUAMOUS CELL; EXOME; HEAD AND NECK NEOPLASMS; HUMANS; SEQUENCE ANALYSIS;

EID: 84928044843     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2014.08.013     Document Type: Review

References (28)

1. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006;24(14):2137-50.
2. Stransky N, Egloff AM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, et al. The mutational landscape of head and neck squamous cell carcinoma. Science 2011;333(6046):1157-60.
3. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011;333(6046):1154-7.
4. Fanjul-Fernandez M, Quesada V, Cabanillas R, Cadinanos J, Fontanil T, Obaya A, et al. Cell-cell adhesion genes CTNNA2 and CTNNA3 are tumour suppressors frequently mutated in laryngeal carcinomas. Nat Commun 2013;4:2531.
5. Nichols AC, Chan-Seng-Yue M, Yoo J, Xu W, Dhaliwal S, Basmaji J, et al. A pilot study comparing HPV-positive and HPV-negative head and neck squamous cell carcinomas by whole exome sequencing. ISRN Oncol 2012;2012:809370.
6. Lui VW, Hedberg ML, Li H, Vangara BS, Pendleton K, Zeng Y, et al. Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers. Cancer Discov 2013;3(7):761-9.
7. India Project Team of the International Cancer Genome. Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrentlymutated genes and molecular subgroups. Nat Commun 2013;4:2873.
8. Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al. Mutational landscape and significance across 12 major cancer types. Nature 2013;502(7471):333-9.
9. Lechner M, Frampton GM, Fenton T, Feber A, Palmer G, Jay A, et al. Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV- Tumors. Genome Med 2013;5(5):49.
10. Nichols AC, Yoo J, Palma DA, Fung K, Franklin JH, Koropatnick J, et al. Frequent mutations in TP53 and CDKN2A found by next-generation sequencing of headand neck cancer cell lines. Arch Otolaryngol Head Neck Surg 2012;138(8):732-9.
11. Perez-Ordonez B, Beauchemin M, Jordan RC. Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 2006;59(5):445-53.
12. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011;11(1):9-22.
13. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers - A different disease. Nat Rev Cancer 2007;7(10):778-90.
14. Lei Y, Lui VW, Grandis JR, Egloff AM. Identification of mutations in the PYRINcontaining NLR genes (NLRP) in head and neck squamous cell carcinoma. PLoS One 2014;9(1):e85619.
15. Lui VW, Peyser ND, Ng PK, Hritz J, Zeng Y, Lu Y, et al. Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer. Proc Natl Acad Sci USA 2014;111(3):1114-9.
16. Li H, Wawrose JS, Gooding WE, Garraway LA, Lui VW, Peyser ND, et al. Genomic analysis of head and neck squamous cell carcinoma cell lines and human tumors: A rational approach to preclinical model selection. Mol Cancer Res 2014;12(4):571-82.
17. Bancroft CC, Chen Z, Yeh J, Sunwoo JB, Yeh NT, Jackson S, et al. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer 2002;99(4):538-48.
18. Grandis JR, Drenning SD, Chakraborty A, Zhou MY, Zeng Q, Pitt AS, et al. Requirement of STAT3 but not STAT1 activation for epidermal growth factor receptor- mediated cell growth In vitro. J Clin Invest 1998;102(7):1385-92.
19. http://www.sanger.ac.uk/genetics/CGP/cosmic/.
20. Chen C, Wei Y, Hummel M, Hoffmann TK, Gross M, Kaufmann AM, et al. Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma. PLoS One 2011;6(1):e16466.
21. Forbes SA, Tang G, Bindal N, Bamford S, Dawson E, Cole C, et al. COSMIC (the Catalogue of Somatic Mutations in Cancer): A resource to investigate acquired mutations in human cancer. Nucleic Acids Res 2010;38:D652-7 (database issue).
22. Mroz EA, Rocco JW. MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma. Oral Oncol 2013;49(3):211-5.
23. Mroz EA, Tward AD, Pickering CR, Myers JN, Ferris RL, Rocco JW. High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinoma. Cancer 2013;119(16): 3034-42.
24. Lander ES, Waterman MS. Genomic mapping by fingerprinting random clones: A mathematical analysis. Genomics 1988;2(3):231-9.
25. Angadi PV, Savitha JK, Rao SS, Sivaranjini Y. Oral field cancerization: current evidence and future perspectives. Oral Maxillofac Surg 2012;16(2):171-80.
26. Nguyen BC, Lefort K, Mandinova A, Antonini D, Devgan V, Della Gatta G, et al. Cross-regulation between NOTCH and P63 in keratinocyte commitment to differentiation. Genes Dev 2006;20(8):1028-42.
27. Song X, Xia R, Li J, Long Z, Ren H, Chen W, et al. Common and complex NOTCH1 mutations in Chinese oral squamous cell carcinoma. Clin Cancer Res 2014;20(3):701-10.
28. Tan Y, Sangfelt O, Spruck C. The FBXW7/hCdc4 tumor suppressor in human cancer. Cancer Lett 2008;271(1):1-12.